Last quarter (Q4 2023), CASI Pharmaceuticals's total revenue was $―, a decrease of -100.00% from the same quarter last year. In Q4, CASI Pharmaceuticals's net income was $―. See CASI Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 34.05M	$ 40.24M	$ 43.11M	$ 30.17M	$ 15.14M	$ 4.13M
Cost of Revenue	$ 3.58M	$ 13.83M	$ 15.83M	$ 12.56M	$ 9.51M	$ 3.94M
Gross Profit	$ 21.98M	$ 26.42M	$ 27.28M	$ 17.61M	$ 5.63M	$ 196.00K
Operating Expense	$ 41.18M	$ 51.70M	$ 53.77M	$ 59.38M	$ 38.95M	$ 39.78M
Operating Income	$ -19.20M	$ -25.28M	$ -26.49M	$ -41.77M	$ -33.31M	$ -39.58M
Net Non Operating Interest Income Expense	$ 66.00K	-	$ 127.00K	$ 321.00K	$ 866.00K	$ 1.06M
Other Income Expense	$ 3.98M	$ -749.00K	$ 6.43M	$ -5.29M	$ -15.06M	$ -6.84M
Pretax Income	$ -29.88M	$ -26.34M	$ -38.28M	$ -35.84M	$ -47.51M	$ -45.36M
Tax Provision	$ 1.98M	$ -81.00K	$ 1.98M	-	$ 0.00	-
Earnings From Equity Interest Net Of Tax	$ 4.48M	$ 566.00K	$ 4.48M	-	-	-
Net Income Common Stockholders	$ -32.42M	$ -26.96M	$ -41.01M	$ -36.65M	$ -48.29M	$ -46.03M
Basic EPS	$ -1.69	$ -2.02	$ -3.01	$ -2.70	$ -4.40	$ -0.48
Diluted EPS	$ -1.69	$ -2.02K	$ -3.01	$ -2.70	$ -4.40	$ -0.48
Basic Average Shares	$ 53.21M	$ 13.36M	$ 13.65M	$ 13.61M	$ 11.05M	$ 95.95M
Diluted Average Shares	$ 53.21M	$ 13.36M	$ 13.65M	$ 13.61M	$ 11.05M	$ 95.95M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 67.86M	$ 65.53M	$ 69.60M	$ 71.94M	$ 48.45M	$ 43.71M
Net Income From Continuing And Discontinued Operation	$ -32.42M	$ -26.96M	$ -41.01M	$ -36.65M	$ -48.29M	$ -46.03M
Normalized Income	$ -7.88M	-	$ -25.16M	-	$ -33.14M	$ -39.19M
Interest Expense	-	-	-	-	-	$ -1.06M
EBIT	$ -29.28M	-	$ -37.56M	$ -36.16M	$ -33.31M	$ -39.58M
EBITDA	$ -27.30M	-	$ -35.14M	$ -34.35M	$ -31.35M	$ -37.43M

Currency in USD

CASI Pharmaceuticals Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing